Penumbra Inc (PEN)
244.84
+4.35
(+1.81%)
USD |
NYSE |
Nov 22, 16:00
244.84
0.00 (0.00%)
Pre-Market: 20:00
Penumbra Price to Book Value: 8.509 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 22, 2024 | 8.509 |
November 21, 2024 | 8.358 |
November 20, 2024 | 8.313 |
November 19, 2024 | 8.241 |
November 18, 2024 | 8.358 |
November 15, 2024 | 8.266 |
November 14, 2024 | 8.116 |
November 13, 2024 | 8.204 |
November 12, 2024 | 8.210 |
November 11, 2024 | 8.413 |
November 08, 2024 | 8.218 |
November 07, 2024 | 8.100 |
November 06, 2024 | 8.122 |
November 05, 2024 | 8.077 |
November 04, 2024 | 7.977 |
November 01, 2024 | 8.108 |
October 31, 2024 | 7.954 |
October 30, 2024 | 7.343 |
October 29, 2024 | 7.286 |
October 28, 2024 | 7.255 |
October 25, 2024 | 7.115 |
October 24, 2024 | 7.179 |
October 23, 2024 | 7.080 |
October 22, 2024 | 7.146 |
October 21, 2024 | 7.183 |
Date | Value |
---|---|
October 18, 2024 | 7.252 |
October 17, 2024 | 7.030 |
October 16, 2024 | 7.140 |
October 15, 2024 | 7.178 |
October 14, 2024 | 7.343 |
October 11, 2024 | 7.059 |
October 10, 2024 | 6.690 |
October 09, 2024 | 6.863 |
October 08, 2024 | 6.768 |
October 07, 2024 | 6.629 |
October 04, 2024 | 6.765 |
October 03, 2024 | 6.774 |
October 02, 2024 | 6.706 |
October 01, 2024 | 6.655 |
September 30, 2024 | 6.750 |
September 27, 2024 | 6.408 |
September 26, 2024 | 6.410 |
September 25, 2024 | 6.252 |
September 24, 2024 | 6.402 |
September 23, 2024 | 6.520 |
September 20, 2024 | 6.523 |
September 19, 2024 | 6.718 |
September 18, 2024 | 6.542 |
September 17, 2024 | 6.257 |
September 16, 2024 | 6.277 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.560
Minimum
Jun 16 2022
17.30
Maximum
Apr 28 2021
10.31
Average
10.18
Median
Price to Book Value Benchmarks
Boston Scientific Corp | 6.406 |
Repligen Corp | 3.961 |
Inari Medical Inc | 6.687 |
Bruker Corp | 4.788 |
QuidelOrtho Corp | 0.8472 |
Price to Book Value Related Metrics
PE Ratio | 284.70 |
PS Ratio | 8.240 |
Price to Free Cash Flow | 71.47 |
Price | 244.84 |
Earnings Yield | 0.35% |
Market Cap | 9.397B |
Operating PE Ratio | 122.20 |
Normalized PE Ratio | 102.31 |